OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / Twitter
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Registration Neckume Lustig & Salomon Stemmer (in the year 1913-1939) » Open Archives
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - ScienceDirect
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
PDF) The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients: A 2-Year Follow-up | Ruth Pat-Horenczyk, Salomon Stemmer, Shlomit Perry, and Yaira Hamama-raz - Academia.edu
מחקר תרגומי בסרטן
Transnational cancer research lab | Felsenstein Medical Research Center
Israel en Panamá - Con el tema "Innovation and Entrepreneurship in the Health Care System" el Dr. Salomon Stemmer, Jefe de Investigación e Innovación en el Instituto de Oncología del Centro Davidoff
Stemmer - List of Frontiers' open access articles
Cancer Patients Develop 'Adequate' Immune Response to COVID Vax | MedPage Today
Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
Ajay Singh - Cofounder & CPTO - speechx | LinkedIn
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
![Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]](https://static.fdocuments.in/img/1200x630/reader022/reader/2020062715/5edc095ead6a402d666687a4/r-1.jpg?t=1632260937 "Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]")
Treating HER2-mutant advanced biliary tract cancer with ... Treating HER2-mutant advanced biliary tract - [PDF Document]
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer
NBER Twitter પર: "Sources of high end-of-life spending for cancer patients, from @danzeltzer, Liran Einav, Amy Finkelstein, Tzvi Shir, Salomon M. Stemmer, and Ran D. Balicer https://t.co/vyosdFbT3M https://t.co/VsajwVZKrx" / Twitter
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
